(Q45049313)
Statements
Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate (English)
Fugazza G
Miglino M
Bruzzone R
Quintino S
Gatti AM
Grasso R
Gobbi M
Frassoni F